Visiox Pharma, LLC, a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to address highly prevalent diseases in need of new treatment options, today announced the closing of a $7M seed round of financing.

Visiox Pharmaceuticals, Inc. is a privately funded biopharmaceutical company dedicated to the development and commercialization of ophthalmic therapeutic candidates to address prevalent diseases in need of new treatment options. With a focus on disrupting and revolutionizing the current market, Visiox is committed to maximizing patient and physician satisfaction.

Visiox Pharma Announces Close Of $7M Seed Round

Description

Company Information

Related People

Visiox Pharma Announces Close Of $7M Seed Round

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information